The scientist’s investigation covers issues in Asthma, Internal medicine, Anesthesia, Placebo and Hereditary angioedema. His Asthma research includes themes of Biomarker and Vital capacity, FEV1/FVC ratio. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Endocrinology.
His Anesthesia study combines topics from a wide range of disciplines, such as Clinical trial, Crossover study, Nasal congestion, Montelukast and Bronchodilator. His biological study spans a wide range of topics, including Randomized controlled trial, Immunology, Corticosteroid, Fluticasone and Asthma Control Questionnaire. His Hereditary angioedema study combines topics in areas such as Angioedema, Ecallantide, Lanadelumab and Family medicine.
His primary scientific interests are in Hereditary angioedema, Internal medicine, Asthma, Dermatology and Surgery. His study looks at the intersection of Hereditary angioedema and topics like Intensive care medicine with Disease. Timothy J. Craig combines subjects such as Gastroenterology, Anesthesia, Placebo and Oncology with his study of Internal medicine.
His research investigates the connection between Anesthesia and topics such as Nasal congestion that intersect with issues in Nasal administration. Placebo is closely attributed to Randomized controlled trial in his work. His research integrates issues of Corticosteroid, Physical therapy and Family medicine in his study of Asthma.
Hereditary angioedema, Internal medicine, C1-inhibitor, Dermatology and Asthma are his primary areas of study. His work deals with themes such as Angioedema, Lanadelumab, Pediatrics and Intensive care medicine, which intersect with Hereditary angioedema. He has researched Internal medicine in several fields, including Gastroenterology, Placebo and Oncology.
His Placebo research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Clinical trial. His study in C1-inhibitor is interdisciplinary in nature, drawing from both Pharmacokinetics, Attack rate and Surgery, Long term prophylaxis. The Asthma study combines topics in areas such as Corticosteroid, Family medicine and Anxiety.
His main research concerns Hereditary angioedema, Internal medicine, C1-inhibitor, Asthma and Angioedema. His Hereditary angioedema research is multidisciplinary, relying on both Clinical trial, Quality of life, Lanadelumab, Adverse effect and Quality of life. The concepts of his Clinical trial study are interwoven with issues in Randomized controlled trial, Crossover study and Pharmacology.
Timothy J. Craig interconnects Gastroenterology and Placebo in the investigation of issues within Internal medicine. His Asthma research incorporates themes from Young adult, MEDLINE and Family medicine. His Angioedema research incorporates elements of Older population, Evidence-based practice, Pediatrics and Optimal management.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.
T Zuberbier;W Aberer;R Asero;A H Abdul Latiff.
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel;Vernon M. Chinchilli;Jean G. Ford;Homer A. Boushey.
The Lancet (2004)
Significant variability in response to inhaled corticosteroids for persistent asthma
Stanley J. Szefler;Richard J. Martin;Tonya Sharp King;Homer A. Boushey.
The Journal of Allergy and Clinical Immunology (2002)
Tiotropium bromide step-up therapy for adults with uncontrolled asthma
Stephen P. Peters;Susan J. Kunselman;Nikolina Icitovic;Wendy C. Moore.
The New England Journal of Medicine (2010)
The diagnosis and management of acute and chronic urticaria: 2014 update.
Jonathan A. Bernstein;David M. Lang;David A. Khan;Timothy Craig.
The Journal of Allergy and Clinical Immunology (2014)
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema
Tom Bowen;Marco Cicardi;Henriette Farkas;Konrad Bork.
Allergy, Asthma & Clinical Immunology (2004)
Daily versus As-Needed Corticosteroids for Mild Persistent Asthma
Homer A. Boushey;Christine A. Sorkness;Tonya S. King;Sean D. Sullivan.
The New England Journal of Medicine (2005)
Smoking Affects Response to Inhaled Corticosteroids or Leukotriene Receptor Antagonists in Asthma
Stephen C. Lazarus;Vernon M. Chinchilli;Nancy J. Rollings;Homer A. Boushey.
American Journal of Respiratory and Critical Care Medicine (2007)
Long-Acting β2-Agonist Monotherapy vs Continued Therapy With Inhaled Corticosteroids in Patients With Persistent Asthma: A Randomized Controlled Trial
Stephen C. Lazarus;Homer A. Boushey;John V. Fahy;Vernon M. Chinchilli.
Nanofiltered C1 Inhibitor Concentrate for Treatment of Hereditary Angioedema
Bruce L. Zuraw;Bruce L. Zuraw;Paula J. Busse;Martha White;Joshua Jacobs.
The New England Journal of Medicine (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: